Skip to Main Content

Paper Details

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection.
medRxiv
3
2021
COVID-19, SARS-CoV, SARS-CoV-2, mAb bamlanivimab, participants, persons
Author NameAffiliation
Alexander L GreningerUniversity of Washington
William A FischerUniversity of North Carolina
Eric S DaarLundquist Institute at Harbor-university of california los angeles Medical Center
David A WohlUniversity of North Carolina
Joseph J EronUniversity of North Carolina
Judith S CurrierUniversity of California los angeles
Judith S CurrierUniversity of California los angeles
Davey M SmithUniversity of California
  • 1 - 8

Datasets

Release 1.2